ORPRO THERAPEUTICS
OrPro Therapeutics,Inc. is a pre-clinical stage biopharmaceutical company headquartered in San Diego, CA. The company’s goal is to develop a breakthrough class of safe, well-tolerated and effective inhaled non-systemic drugs based on the thioredoxin active site for the treatment of patients with cystic fibrosis (CF) and other serious obstructive pulmonary diseases.
ORPRO THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.orprotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
858-242-1557
Email Addresses:
[email protected]
Total Funding:
4.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Orpro Therapeutics
Official Site Inspections
http://www.orprotherapeutics.com
- Host name: 103.4.180.107.host.secureserver.net
- IP address: 107.180.4.103
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Orpro Therapeutics" on Search Engine
About Us – OrPro Therapeutics, Inc.
OrPro Therapeutics, Inc. (San Diego, CA) is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for treatment of diseases of the lung …See details»
Orpro Therapeutics - Crunchbase Company Profile & Funding
OrPro Therapeutics,Inc. is a pre-clinical stage biopharmaceutical company headquartered in San Diego, CA. The company’s goal is to develop a breakthrough class of safe, well …See details»
Management Team – OrPro Therapeutics, Inc.
Management Team. Board of Directors. Scientific and Medical Advisors. Led by CEO and Founder Peter B. Heifetz, Ph.D., and Chairman Cam Garner, the OrPro team has …See details»
OrPro Therapeutics Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for OrPro Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Orpro Therapeutics | LinkedIn
OrPro Therapeutics, Inc. is a San Diego preclinical-stage Johnson & Johnson JLABS alumni company addressing large unmet medical needs in acute and chronic respiratory, …See details»
OrPro Therapeutics Receives $2.147M Therapeutic Development …
OrPro Therapeutics, Inc is a privately held preclinical-stage company pioneering a novel biologic drug platform for treating severe respiratory, ophthalmic, and mucosal diseases.See details»
OrPro Therapeutics Advances a New Inhalation Treatment …
OrPro Therapeutics, Inc is a privately held preclinical-stage company pioneering a novel non-systemic biologic drug platform for treating severe respiratory and mucosal …See details»
OrPro Therapeutics Advances a New Inhalation Treatment
OrPro Therapeutics, Inc is a privately held preclinical-stage company pioneering a novel non-systemic biologic drug platform for treating severe respiratory and mucosal …See details»
OrPro Therapeutics - Connect San Diego
July 19, 2022. Meet OrPro Therapeutics. OrPro Therapeutics is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for …See details»
Orpro Therapeutics - Funding, Financials, Valuation & Investors
$4.5M. in funding over 2 rounds. Their latest funding was raised on Jul 19, 2022 from a Grant round. Orpro Therapeutics is funded by U.S. Department of Defense. Orpro …See details»
ORPRO THERAPEUTICS, INC. | VentureRadar
"OrPro Therapeutics is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for treatment of diseases of the lung and other epithelial …See details»
OrPro Strategy – OrPro Therapeutics, Inc.
Overview. CF Treatment. OrPro Strategy. OrPro Therapeutics is targeting the functional mucus abnormalities which link genetic CFTR ion-transport defects to the obstruction, …See details»
ORPRO THERAPEUTICS, INC. | VentureRadar
OrPro Therapeutics is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for treatment of diseases of the lung and other epithelial …See details»
Orpro Therapeutics - Contacts, Employees, Board Members
Peter Heifetz CEO. Jeff Raser COO. Unlock even more features with Crunchbase Pro. Start Your Free Trial. OrPro Therapeutics develops recombinant thioredoxin for the treatment …See details»
Research programme: lung disorder therapeutics - OrPro …
Drug Profile. Research programme: lung disorder therapeutics - OrPro Therapeutics. Alternative Names: Theradux. Latest Information Update: 28 Aug 2022. Price : $50 * Buy …See details»
OrPro Therapeutics Advances a New Inhalation Treatment …
SAN DIEGO, CA – May 28, 2020 – OrPro Therapeutics announced today that it is expanding its patented technology platform for treatment of acute and chronic airway …See details»
ORP-100 - Drug Targets, Indications, Patents - Synapse
Overview. Basic Info. Drug Type. Enzyme. Synonyms. Recombinant modified human thioredoxin 1, Theradux, ORP 100 S. + [1] Target. TXN. Mechanism. TXN modulators …See details»
COVID-19 – OrPro Therapeutics, Inc.
Overview. COVID-19 Treatment Challenges. OrPro Therapeutics is developing ORP100S, a novel biologic therapy to treat inflammation and obstruction in the lung associated with …See details»
ORP 100 S - AdisInsight - Springer
ORP 100 S is being developed by OrPro Therapeutics for the treatment of cystic fibrosis, non-CF bronchiectasis, COVID-2019 infections and acute radiation.See details»
Orpro Therapeutics - Crunchbase
Companies like Orpro Therapeutics include Affimed, Semma Therapeutics, and Proteostasis Therapeutics. Proteostasis Therapeutics Cambridge , Massachusetts , …See details»